15 Stocks with Buy Ratings that Hedge Funds Love

Page 3 of 13

11. IQVIA Holdings Inc. (NYSE:IQV)

No. of Hedge Funds: 51

Value of the hedge funds: $2.33 billion

Based in North Carolina, IQVIA Holdings Inc. (NYSE:IQV) provides advanced analytics, clinical research, and technology solutions to the life sciences sector. The company focuses on using clinical trials, real-world evidence, and AI-enabled drug development to provide the best solutions. It serves pharmaceutical, biotech, and healthcare clients globally. The company’s proprietary IQVIA CORE platform allows it to stand out from its competitors in the market.

Backed by 51 hedge funds at the end of Q4 2024, IQVIA Holdings Inc. (NYSE:IQV) has $2.33 billion in investments, signaling strong institutional interest. Accordingly, the company generated a 5.5% growth in revenue in 2024. The company has renewed all large pharma strategic partnerships and expanded the scope of work in several partnerships, which is expected to contribute to further value creation in 2025. The technological capabilities have also increased with the introduction of 60 innovations, including 39 AI-enabled applications. In its 2025 outlook, the company reaffirms revenue growth of 4% to 70%, which is interpreted positively among the shareholders.

The EPS growth of IQVIA Holdings Inc. (NYSE:IQV) over the past five years stands at 50.90%, affirming its notable role in the healthcare sector. The stock has earned a Strong Buy rating from analysts, indicating high expectations regarding the company’s future growth.

Page 3 of 13